Why a missing signed receipt becomes effectively irrecoverable once the vessel departs — and how to prevent it
Most FDA disputes are inconvenient. A missing vendor invoice takes a week to source. A rate discrepancy takes a few days to resolve with a tariff reference. A mooring charge misalignment can be corrected with a Statement of Facts amendment.
Cash to Master (CTM) disputes are different. When the signed receipt is missing and the vessel has already departed, the person who needs to sign it is at sea, at the next port, or on a different vessel entirely. The resolution bottleneck is not documentation — it is geography. According to industry dispute patterns, CTM receipt disputes carry a typical resolution delay of 21 to 45 days. That is the longest average delay of any FDA dispute category.
What Cash to Master Is — and Why Principals Scrutinize It Most Heavily
Cash to Master is a cash disbursement made directly to the vessel's master on behalf of the principal, used to cover onboard expenses, crew advances, or petty cash needs during the port call. It is the only line item on most FDAs that involves a physical cash transaction — which makes it inherently harder to document than electronic payments and significantly more exposed to principal scrutiny.
Principals scrutinize CTM harder than any other line item for a straightforward reason: it is cash. Every other charge on the FDA has a third-party vendor invoice — a pilotage authority, a tug company, a stevedore. CTM has only the agent's record of handing money to an individual. Without a signed receipt from that individual, the principal has no independent verification that the disbursement occurred at all.
This is not a trust problem. It is a documentation problem. Principals who have no reason to doubt their agent will still flag an undocumented CTM, because approving it without a signed receipt creates an audit exposure they cannot absorb.
The Four Ways a CTM Dispute Gets Triggered
Cash to Master disputes cluster around four distinct triggers, each requiring a different documentation response.
1. The signed receipt is missing
The most common trigger by a significant margin. The master signed a receipt at the time of disbursement but it was not scanned and attached before the vessel departed. The agent has paid the cash, the master has the money, but there is no verifiable record. Resolution requires obtaining the master's signature retrospectively — which means tracking down the vessel and the individual.
2. The exchange rate is unverifiable
When CTM is disbursed in local currency and billed in the principal's accounting currency, the exchange rate applied must be referenced to a verifiable source — typically the bank rate at the time of transaction. Agents who apply an internal rate, or who cannot reference the rate to a dated bank record, face disputes on the conversion arithmetic alone.
3. The amount is disputed
The principal believes the advance was larger than operationally necessary. This dispute is almost impossible to win without written authorization from the principal or ship management company specifying the CTM amount before it was disbursed. A master's verbal request is not sufficient. A follow-up email from the vessel confirming the request is the minimum documentation.
4. The authorization itself is challenged
In some cases, the principal disputes whether CTM was authorized at all — particularly when the advance was large or when the vessel's management company has strict thresholds for cash disbursements. Agents who disburse CTM on the master's request alone, without confirming authorization with the principal or management company, carry this exposure on every port call.
Why Vessel Departure Is the Hard Deadline
Every other FDA dispute can be resolved with documents. CTM disputes can only be resolved with a specific person's signature. Once that person's vessel has sailed, the resolution path narrows immediately.
This makes the CTM receipt the only FDA document that should be treated as a departure-blocking checkpoint. The FDA should not leave the agency until the signed and scanned receipt is attached. Not after. Before. If the receipt is missing at departure, the agent should flag it immediately and begin the chase while the vessel is still in communication range.
The practical process: disburse, obtain the signed receipt at the point of disbursement, scan it immediately, attach it to the port call record. Do not rely on collecting it at departure. Masters manage dozens of interactions during a port call; a receipt handed over at cash disbursement is far more likely to be signed and returned than one requested at gangway removal.
Frequently Asked Questions
Does the Cash to Master receipt need to be signed by the master specifically, or can another officer sign?
The receipt should be signed by the master, as CTM is a disbursement made on behalf of the principal to the vessel's commanding officer. In practice, a chief officer signature is sometimes accepted when the master is unavailable at the point of disbursement — but this should be documented with a note explaining why the master did not sign. Principals who challenge CTM authorization will look at the signatory first.
What exchange rate should be used for Cash to Master disbursements in local currency?
The exchange rate applied should be the bank's published rate at the time of the transaction, referenced to a specific date and source. The agent should retain the bank rate confirmation or transaction record and attach it to the FDA. Internal or estimated rates that cannot be referenced to a dated, verifiable source are a reliable dispute trigger on the conversion line.
What should a ship agent do if the vessel departs before the CTM receipt is signed and returned?
Flag the missing receipt to the principal immediately — do not wait until the FDA is submitted. Contact the vessel directly via the ship management company to request that the master sign and return the receipt by email or scan. Submit the FDA with a clear note that the receipt is being obtained and will be attached upon receipt. Proactive disclosure gives the principal a manageable query rather than a surprise dispute when the FDA arrives without documentation.
The Full Picture: All 12 Line Items
Cash to Master is one of four authorization disputes covered in our FDA Disputes Field Guide. The full guide addresses all 12 line items that drive FDA pushback, with specific documentation checklists for each and an 18-checkpoint pre-submission process to work through before every FDA is submitted. Download it Today.
